Key Dates And Studies In Modern Peptide – SET FOR SET

Peptides are one of the crucial debated matters in well being and health right now. Critics usually level to the truth that many peptides aren’t at present FDA-approved, and that concern is comprehensible.

The present regulatory panorama creates respectable questions on sourcing, purity, and high quality management. Nonetheless, an absence of FDA approval doesn’t routinely imply a compound is ineffective or “snake oil.” Peptides have a protracted historical past of analysis and improvement, and a number of other have generated important curiosity throughout the medical group.

The aim of this text is to not argue that peptides are definitively protected or efficient. Slightly, we really feel the dialog on each side could be missing. Subsequently, it’s needed to look at their historical past, discover the analysis behind them, and clarify why these compounds proceed to draw consideration from researchers, clinicians, and shoppers alike.

What Are Peptides? Fast Recap

First, let’s go over what peptides particularly are, after which pinpoint what the peptides we’re speaking about on this article are.

Peptides are merely brief chains of amino acids, the identical constructing blocks that make up proteins. In actual fact, “protein” and “peptide” merely outline a compound as having both a big chain of amino acids (protein) or a brief chain (peptide).

• Proteins = 50+ amino acids (normally encompass tons of, creating advanced constructions)
• Peptides = 2–50 amino acids with extremely particular capabilities

How Do Peptides Work?

Many medication work together with a number of tissues and receptors all through the physique. Whereas this may be efficient, it may additionally result in unintended unintended effects.

Peptides are sometimes engaging to peptides as a result of many are designed to imitate naturally occurring signaling molecules. This permits them to work together with particular receptors and organic pathways concerned in a selected operate.

For instance: 

• Semaglutide (Ozempic) is an artificial peptide that mimics GLP-1, a hormone concerned in urge for food regulation and blood sugar management.
• CJC-1295 and Ipamorelin are designed to affect development hormone launch by appearing on particular signaling pathways.
• GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding peptide that seems to play a task in tissue restore, collagen manufacturing, and wound therapeutic.

This capacity to focus on specific organic processes is one cause peptides have generated a lot curiosity amongst researchers and clinicians.

What Are The New Peptides?

Peptides aren’t new and are already closely used. Some widespread ones are:

• Insulin will be the mostly used peptide to deal with diabetes
• GLP1s are all peptides
• Collagen peptides are “technically” peptides and utilized in skincare
• Oxytocin, the “love chemical,” is very used throughout births.

However this is not what we’re speaking about. Just lately, there was a brand new wave of therapeutic peptides, many used for efficiency, restoration, and aesthetics. 

• BPC-157
• MOTS-C
• GHK-CU
• TB-4

These new therapeutic peptides share an advanced historical past when it comes to their use and legality. This is what has garnered a lot curiosity. Each good and unhealthy.

Discovery Dates Of The 12 Peptides Underneath Evaluation

Earlier than we get into the timeline, we first need to acknowledge the invention date of the 12 peptides currently under review with the FDA.

These are those most care about, and as it is best to; the others have been deemed to be too insignificant by the FDA to garner a deeper look and are much more experimental with much less knowledge.

Understand that it may be tough to differentiate and decide precise dates as a consequence of totally different terminology used: “found”, “acknowledged”, “described.”

Regardless, you will discover that the majority of those have been round for much longer than you suppose; there is a good probability they’re older than you!

1. GHK-Cu 1973: (Recognized in human plasma by Loren Pickart)

• Main Focus: Tissue regeneration and anti-aging.
• Therapeutic Purposes: Used primarily in dermatology and wound care to stimulate collagen manufacturing, speed up wound therapeutic, and promote pores and skin and hair follicle regeneration

2. DSIP (Emideltide) 1974: (First remoted from rabbit cerebral venous blood)

• Main Focus: Sleep and neuroendocrine regulation.
• Therapeutic Purposes: Studied for treating extreme insomnia, regulating disrupted circadian rhythms, lowering emotional stress, and mitigating opioid or alcohol withdrawal signs.

3. Thymosin Beta-4 1981: (Sequenced and characterised from calf thymus tissue)

• Main Focus: Mobile therapeutic and tissue restore.
• Therapeutic Purposes: Closely researched for wound therapeutic, corneal accidents, cardiovascular restore following myocardial infarction (coronary heart assault), and lowering scar tissue formation.

4. Semax Nineteen Eighties: (Developed by Soviet researchers / Institute of Molecular Genetics)

• Main Focus: Neuroprotection and cognitive enhancement.
• Therapeutic Purposes: Clinically utilized for ischemic stroke restoration, transient ischemic assaults (TIAs), optic nerve illness, and managing ADHD or reminiscence decline. 

5. Melanotan II 1987: (Synthesized on the College of Arizona)

• Main Focus: Tanning induction and sexual dysfunction.
• Therapeutic Purposes: Initially engineered as a photoprotective agent in opposition to pores and skin most cancers by inducing melanin manufacturing; additionally researched for treating erectile dysfunction.

6. KPV 1989: (Acknowledged because the lively anti-inflammatory fragment of α-MSH)

• Main Focus: Mobile anti-inflammatory and intestine restore.
• Therapeutic Purposes: Extensively studied for inflammatory bowel illness (IBD/colitis), mast cell activation syndrome, and inflammatory pores and skin circumstances like eczema or psoriasis.

7. Epitalon, Early Nineties: (St. Petersburg Institute of Bioregulation)

• Main Focus: Gerontology, longevity, and telomere biology.
• Therapeutic Purposes: Researched as an anti-aging compound designed to upregulate telomerase exercise, prolong telomere size, and normalize pineal gland melatonin secretion.

8. BPC-157 1993: (First described within the scientific literature)

• Main Focus: Gastrointestinal and musculoskeletal therapeutic.
• Therapeutic Purposes: Evaluated for therapeutic tender tissue accidents (tendons, ligaments, muscular tissues), gastric ulcers, leaky intestine syndrome, and inflammatory joint ailments.

9. LL-37 1995: (Recognized because the lively human cathelicidin antimicrobial peptide)

• Main Focus: Antimicrobial protection and immune modulation.
• Therapeutic Purposes: Investigated as a topical remedy for persistent diabetic foot ulcers, surgical web site infections, and combating drug-resistant bacterial biofilms.

10. PEG-MGF 2002: (Engineered as a pegylated long-acting MGF variant)

• Main Focus: Muscle losing and native tissue development.
• Therapeutic Purposes: Researched for reversing sarcopenia (age-related muscle loss), treating muscle-wasting ailments like dystrophy, and accelerating restoration from extreme muscle tears.

11. Dihexa 2011–2012: (Synthesized and patented by Washington State College)

• Main Focus: Cognitive restoration and neurodegeneration.
• Therapeutic Purposes: Engineered particularly to fight Alzheimer’s illness, dementia, and traumatic mind damage (TBI) by stimulating huge synaptic connectivity (synaptogenesis).

12. MOTS-c 2015: (Found as a mitochondrial-derived signaling peptide)

• Main Focus: Mitochondrial well being and metabolic restoration.
• Therapeutic Purposes: Evaluated for treating kind 2 diabetes, weight problems, insulin resistance, and age-related train intolerance by appearing as an train mimetic on the mobile degree.

Timeline Of Peptides In Drugs

Of the 12 peptides at present beneath FDA evaluation, 9 hint their origins to discoveries made earlier than the yr 2000, with a number of having greater than 40 years of documented scientific historical past.

However these are the “new” peptides, and their historical past goes again a lot farther.

Listed below are some key occasions and occasions all through their 120+ yr historical past. It ought to go with out saying, these are solely a handful of significant occasions.

1901 – First Artificial Peptides Created

• Nobel laureate chemist Emil Fischer created the very first artificial peptide (glycylglycine) (Goodman, 2003).
• Whereas a quite simple dipeptide (simply two amino acids), he proved it was attainable for researchers to affix amino acids.

1921–1922 – Isolation and First Medical Use of Insulin

• In 1921, scientists Frederick Banting and Charles Finest efficiently remoted insulin from animal pancreases (Banting et al., 2022).
• In 1922, 14-year-old Leonard Thompson turned the primary human to obtain an insulin injection to deal with kind 1 diabetes.

1953–1954 – First Artificial Peptides (Oxytocin)

• Chemist Vincent du Vigneaud efficiently mapped the sequence of oxytocin and vasopressin and efficiently synthesized them in a lab (du Vigneaud).
• This proved that researchers might synthesize peptides with out counting on animal harvesting. 
• Du Vigneaud wins the 1955 Nobel Prize in Chemistry.

1973 – GHK-Cu Found in Human Plasma 

• Biochemist Dr. Loren Pickart first isolates the favored peptide GHK-Cu.
• GHK-Cu is a novel copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine) from human albumin (Pickartt & Thaler, 1973).
• Pickart observes that the peptide causes previous, getting older liver cells to start functioning like younger cells. This marks the foundational discovery of GHK-Cu as a robust mobile reworking and gene-modulating agent. 

1978–1982 – The First Biotech Recombinant Peptide (Humulin)

• In 1982, Genentech created Humulin by modifying E. coli micro organism to develop human insulin chains (Goeddel et al., 1979). 
• This was the first-ever recombinant DNA drug given FDA approval for people. This helped remedy industrial purity and provide limitations. 

Nineteen Eighties – Soviet “Secret” Longevity Bioregulators & Epitalon

• Dr. Vladimir Khavinson and his specialised staff of Russian navy researchers started extracting brief peptide chains from the organs of cattle to increase the organic resilience of troopers and cosmonauts (Anisimov et al., 1994). 
• His staff synthesized Epitalon, a peptide modeled after a pineal gland extract.  
• This sparked a large physique of Russian literature targeted on telomere preservation and mobile lifespan.

1981 – The Full Sequencing of Thymosin Beta-4 (TB-500 precursor)

• Constructing on earlier calf thymus analysis by Dr. Allan Goldstein, scientists efficiently map the entire amino acid sequence of Bovine Thymosin Beta-4 (Low et al., 1981).
• Thymosin Beta-4 is a essential regulator of cell migration and actin polymerization.
• Many years later, TB-500, a 17-amino-acid artificial fragment of this chain, turned extraordinarily widespread within the wellness group.

1985 – Leuprolide, The First Closely Modified Peptide Accepted 

• In 1985, Leuproglide was the primary closely modified artificial peptide accredited by the FDA for human use (Chwalisz, 2022)
• Whereas particularly accredited to deal with prostate most cancers, this demonstrated modified peptide can efficiently face up to bodily degradation.

1986 – The Discovery of GLP-1

• In 1986, researchers formally remoted Glucagon-Like Peptide-1 (GLP-1) (Mojsov et al., 1986)
• This singular discovery resulted within the following a long time of analysis resulting in exenatide, liraglutide, and semaglutide. 
• Whereas peptides have been used for over a century, the success of GLP-1 medication arguably sparked the trendy peptide increase in most people. 

1987 – Melanotan Developed on the College of Arizona

• Researchers Dr. Victor Hruby and Dr. Mac Hadley synthesized Melanotan, a long-acting analog of alpha-melanocyte-stimulating hormone (α-MSH) (Al-Obeidi, et al., 1989)
• Melanotan demonstrated that peptides might be engineered for higher efficiency and length and would play a task in peptide design.

1993 – BPC-157 Is First Described

• Dr. Predrag Sikiric and colleagues publish early analysis on BPC-157, a secure gastric peptide remoted from human gastric juice.
• This marks the start of BPC-157 analysis and establishes the peptide as a possible regulator of tissue restore and gastrointestinal therapeutic.
• BPC-157 has develop into one of the crucial widespread peptides.

1998 – GHRP-6 Analysis Expands

• Researchers more and more examine Progress Hormone Releasing Peptide-6 (GHRP-6) for its capacity to stimulate development hormone secretion.
• GHRP-6 helps show that small artificial peptides can affect main endocrine pathways with out administering hormones immediately.

2003 – Tendon Therapeutic Analysis Printed

• Researchers publish one of many most cited research demonstrating accelerated Achilles tendon therapeutic with BPC-157 in rodents (Staresinic et al., 2003).
• Curiosity in BPC-157 expands past gastrointestinal analysis into sports activities medication, damage restoration, and musculoskeletal regeneration.

2006 – CJC-1295 Human Trials Start

• Human trials for CJC-1295, a long-acting development hormone-releasing hormone, start testing its capacity to raise development hormone and IGF-1 ranges (Teichman et al., 2006).
• CJC-1295 demonstrates how peptide engineering can dramatically prolong half-life whereas sustaining organic exercise.

2006 – Human BPC-157 Analysis Reported

• Researchers report investigating BPC-157 in sufferers with inflammatory bowel illness (Skiric et al, 2006).
• Though large-scale medical improvement by no means adopted, this represents one of many earliest reported human functions of BPC-157.

2010–2011 – Musculoskeletal Peptide Analysis Expands

• A number of research examine peptides equivalent to BPC-157 and Thymosin Beta-4 for tendon, ligament, muscle, and connective tissue therapeutic.
• This marks a shift the place peptide analysis begins shifting in direction of regenerative medication and recovery-focused functions.

2015 – Human Security Trial Registered

• A human security examine involving oral BPC-157 is formally registered.
• Nonetheless, this human trial was in the end deserted. 
• Nonetheless, this represents one other step towards medical analysis and displays rising scientific curiosity in therapeutic peptide functions.

2022 – WADA Prohibits BPC-157

• The World Anti-Doping Company (WADA) provides BPC-157 to its Prohibited Listing.
• Satirically, this brings extra consideration to BPC-157 amongst athletes, coaches, and in the end the broader performance-enhancement group.

September 2023 – FDA Restricts 19 Peptides From Compounding

• The FDA locations 19 peptides into Class 2 consideration, stopping them from having the ability to be compounded whereas beneath evaluation.
• This positioned important restrictions on routine compounding whereas they remained beneath evaluation.
• Peptide regulation turns into a significant matter inside the medical, wellness, and compounding industries.

2025 – Peptide Market Explodes

• Demand for peptide therapies reaches unprecedented ranges as wellness clinics, telehealth firms, and shoppers more and more undertake peptide-based interventions.
• Peptides transition from a distinct segment medical matter right into a mainstream well being, longevity, and wellness phenomenon.

April 2026 – FDA Proposes Eradicating 12 Peptides From Class 2

• The FDA proclaims plans to take away 12 beforehand restricted peptides from Class 2 and reevaluate their regulatory standing.
• The proposal indicators a probably important change in peptide accessibility and future compounding practices.

July 2026 – FDA Advisory Evaluation Scheduled

• The FDA schedules an advisory evaluation to additional consider the regulatory standing of a number of compounded peptides.
• The end result might assist form the long run regulatory panorama for peptide therapies in the US.

Research On Peptides

Now, let’s take a look at among the research that exist. A typical declare is that there is little knowledge.  The issue is that there are such a lot of totally different peptides that it is inconceivable to present a single blanket reply.

Animal Research

When talking about peptides, the widespread argument is most knowledge is on rodents. Extra particularly, it is normally offered in a fashion that downplays the depth of analysis that exists, i.e., “You are injecting your self with a compound that has 3 mouse research”.

This drastically undermines the depth of analysis that exists. We collected knowledge on among the extra widespread peptides to supply an estimate of animal research that exist.

Some giant evaluations cite what number of they included, which makes it simple. For others, we needed to estimate by working the reference lists of evaluations (usually 100+) via a number of AI functions and evaluating their findings.

Subsequently, these aren’t exact measurements however quite affordable estimates. Moreover, this isn’t meant to recommend it is best to go and use these. It is merely to point out that. 

BPC-157

• Vaseraddi et al., 2025: A complete of 544 articles from 1993 to 2024 have been recognized regarding BPC-157 and joint well being. After duplicates have been eliminated, 36 research have been included.
• Demeitras et al., 2025: Listing round 30 research on BPC-157 on rodents regarding organ tissue

Thymosin β4 (TB-500)

• Crockford et al., 2010: Critiques roughly 20 years of preclinical analysis throughout wound therapeutic, cardiac restore, corneal therapeutic, and tissue regeneration.
• Maar et al., 2021: Giant evaluation on TB-4 and anti-aging, which cites 40-50 rodent research.

Epitalon

• Araj et al., 2025: Evaluation containing 30–40 rodent research inspecting lifespan, most cancers, getting older biomarkers, neuroendocrine operate, immunity, retinal well being, kidney operate, oxidative stress, and reproductive getting older.
• Anisimov et al., 2003: Lifespan examine in mice adopted animals all through life.

MOTS-C

• Wan et al., 2023: Evaluation of MOTS-c analysis comprises roughly 17–21 rodent research associated to metabolism, getting older, stress resistance, cardiovascular operate, irritation, bone metabolism, train adaptation, and aging-related physiology.
• Zheng et al., 2023: Evaluation of MOTS-c biology and comprises roughly 10–13 rodent research

Human Research

If the anti-peptide crowd actually wished to critique peptides, you’d suppose they might speak in regards to the human research that do exist. However they do not. Slightly, a standard declare is that “there is no human knowledge” or “restricted human knowledge”.

On the whole, that is true as in depth human knowledge is missing. Nonetheless, there are research that exist, and while you have a look at them, two issues come out:

1. Whereas most are small in dimension, the outcomes are overwhelmingly optimistic. Some research present optimistic ends in 85% of the members (Lee & Padgett, 2021). 
2. There are nearly no important opposed results in most research. The first points are typically on the injection level (redness, itchiness) and intestine points (diarrhea). 

BPC-157 ( BPC-157 + TB-4)

• Veljaca et al., 2003:  Sufferers with ulcerative colitis reportedly confirmed enchancment following BPC-157 remedy. This is usually cited as one of many few human investigations of BPC-157.
• Lee & Padgett, 2021: 14 of 16 sufferers receiving remedy noticed important reductions in knee ache for six+ months.
• BPC-157 Security Trial (NCT02637284): A human trial evaluating oral BPC-157 for inflammatory bowel illness was registered. Restricted outcomes have been publicly launched.

CJC-1295

• Teichman et al., 2006: Wholesome women and men (21– 61 years previous) noticed a rise in development hormone secretion and IGF1 ranges.
• Ionescu et al., 2006: 20 wholesome males (20-40yo) noticed a rise in development hormone secretion and IGF1 ranges.

Ipamorelin

• (Madsbad et al., 1999): Wholesome adults confirmed fast will increase in development hormone with out spikes in cortisol or ACTH.
• Part II Trial (discontinued): Failed to enhance abdomen and bowel motility in sufferers recovering from surgical procedure.

Tesamorelin

• Falutz et al., 2010: 404 HIV sufferers noticed an 18% discount in stomach fats after 52 weeks of each day use.
• Adrian et al., 2019: Grownup sufferers skilled a measurable improve in muscle dimension and density.
• Stanley et al., 2019: Grownup sufferers had important reductions in liver fats accumulation.

Sermorelin

• Prakash & Goa, 1999: Youngsters with development deficiencies skilled protected, accelerated top development.
• Corpas et al., 1992: Aged males efficiently restored youthful development hormone and IGF-1 ranges.

Melanotan II

• Dorr et al., 1996: Wholesome volunteers noticed elevated pores and skin tanning together with unintended effects like nausea.
• Wessells et al., 1998: Males with erectile dysfunction achieved spontaneous erections however skilled extreme nausea.

Epitalon 

• Khavinson et al., 2003: Aged sufferers tracked over a number of years confirmed decrease mortality and higher immune operate.
• Anisimov et al., 2006: Older adults restored low melatonin ranges and corrected their sleep cycles. 

Semax

• Gusev et al., 2018: Stroke sufferers given the nasal spray recovered their cognitive and neurological capabilities quicker.
• Polunin et al., 2012: Sufferers with optic nerve harm achieved measurable enhancements in eyesight.

Selank

• Zozulya et al., 2008: Anxiousness sufferers diminished their signs as successfully as conventional medicine with out feeling groggy.
• Radionova et al., 2011: Anxious people noticed lowered physiological irritation markers throughout demanding durations.

Ultimate Say: Peptides Historical past, Research, and What It Means

In case you’re like most individuals, you are most likely shocked by how a lot historical past and analysis peptides even have behind them. So does that imply it is best to run out and purchase some? Not fairly.

Whereas the analysis is fascinating and plenty of peptides present promise, this shouldn’t be taken as conclusive proof of their security or effectiveness.

The most important difficulty right now is guaranteeing clear, high-quality manufacturing. As a result of many peptides stay confined to the gray market, oversight and high quality management could be restricted, rising the chance of mislabeled, underdosed, or contaminated merchandise.

On the identical time, extra human trials are wanted earlier than broad acceptance can happen. And that is the place the dialog ought to be targeted. If you have a look at the historical past of peptides and the accompanying analysis, it is clear that many warrant additional investigation. Slightly than merely dismissing them as a result of they lack FDA approval, we ought to be asking how quality-controlled analysis and manufacturing could be expanded.

The truth is that persons are searching for easy, efficient, and cost-effective remedies. Peptides might in the end show to be that answer, and with the analysis we do have, they appear very promising. Or perhaps they will not. We do not know. 

Presently, we won’t be optimistic, and solely extra analysis will decide that.

What we do know is that proscribing analysis and improvement will not make these compounds disappear. It will not change whether or not they’re efficient. It is going to solely make FDA approval tougher and push demand additional into the unregulated market, the place high quality management and shopper security develop into even higher issues.

References

1. Adrian, S., Amati, F., Gill, T. M., Vaughan, D. E., & Nair, Ok. S. (2019). The expansion hormone releasing hormone analogue, tesamorelin, decreases muscle fats and will increase muscle space in adults with HIV. The Journal of Frailty & Getting older, 8(3), 154–160. https://www.sciencedirect.com/science/article/pii/S2260134124003049 
2. Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). As soon as-daily administration of CJC-1295, a long-acting development hormone-releasing hormone analog, normalizes development within the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290-E1294. https://doi.org/10.1152/ajpendo.00201.2006 
3. Al-Obeidi, F., Hadley, M. E., Pettitt, B. M., & Hruby, V. J. (1989). Design of potent linear alpha-melanocyte-stimulating hormone antagonists. Journal of Medicinal Chemistry, 32(1), 174–179.  https://experts.arizona.edu/en/publications/design-of-potent-linear-melanotropin-410-analogues-modified-in-po/
4. Anisimov, V. N., Khavinson, V. Ok.h, & Morozov, V. G. (1994). Twenty years of examine on results of pineal peptide preparation: epithalamin in experimental gerontology and oncology. Annals of the New York Academy of Sciences, 719, 483–493. https://doi.org/10.1111/j.1749-6632.1994.tb56853.x
5. Araj, S. Ok., Brzezik, J., Mądra-Gackowska, Ok., & Szeleszczuk, Ł. (2025). Overview of Epitalon—Extremely Bioactive Pineal Tetrapeptide with Promising Properties. Worldwide Journal of Molecular Sciences, 26(6), 2691. https://doi.org/10.3390/ijms26062691
6. Banting, F. G., Finest, C. H., Collip, J. B., Campbell, W. R., & Fletcher, A. A. (1922). Pancreatic Extracts within the Therapy of Diabetes Mellitus. Canadian Medical Affiliation journal, 12(3), 141–146. https://pubmed.ncbi.nlm.nih.gov/20314060/
7. Chwalisz Ok. (2022). Scientific improvement of the GnRH agonist leuprolide acetate depot. F&S stories, 4(2 Suppl), 33–39. https://doi.org/10.1016/j.xfre.2022.11.011
8. Corpas, E., Harman, S. M., Pineyro, M. A., Roberson, R., & Blackman, M. R. (1992). Progress hormone-releasing hormone (1-29) twice daily-infusion restores youthful profiles of development hormone and insulin-like development factor-I secretion in wholesome aged males. Journal of Scientific Endocrinology & Metabolism, 75(2), 530–535. https://academic.oup.com/jcem/article-abstract/75/2/530/2649366
9. du Vigneaud, V., Ressler, C., Swan, J. M., Roberts, C. W., Katsoyannis, P. G., & Gordon, S. (1953). The synthesis of an octapeptide amide with the hormonal exercise of oxytocin. Journal of the American Chemical Society, 75(19), 4879–4880. doi.org
10. Dorr, R. T., Strains, R., Levine, N., Brooks, C., Xiang, L., Hruby, V. J., & Hadley, M. E. (1996). Analysis of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I medical examine. Life Sciences, 58(20), 1777–1784. https://www.sciencedirect.com/science/article/abs/pii/0024320596001609
11. Falutz, J., Allas, S., Blot, Ok., Potvin, D., Kotler, D., Somero, M., Berger, D., Brown, S., Marsolais, C., & Grinspoon, S. (2010). Lengthy-term security and results of tesamorelin, a development hormone-releasing issue analogue, in HIV-infected sufferers with stomach lipodystrophy. Journal of Acquired Immune Deficiency Syndromes, 53(3), 311–322. https://journals.lww.com/aidsonline/abstract/2008/09120
12. Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyneker, H. L., Yansura, D. G., Crea, R., Hirose, T., Kraszewski, A., Itakura, Ok., & Riggs, A. D. (1979). Expression in Escherichia coli of chemically synthesized genes for human insulin. Proceedings of the Nationwide Academy of Sciences of the US of America, 76(1), 106–110. https://doi.org/10.1073/pnas.76.1.106
13. Goodman, M., Cai, W. and Smith, N.D. (2003), The daring legacy of Emil Fischer. J. Peptide Sci., 9: 594-603. https://doi.org/10.1002/psc.476
14. Fischer E, Fourneau E. Ueber einige Derivate des Glycocolls. Ber Dtsch Chem Ges. 1901;34(2):2868–2877.
15. Gusev, E. I., Skvortsova, V. I., & Semenov, P. A. (2018). Efficacy and security of the artificial peptide Semax in acute ischemic stroke: Journal of Neurology and Psychiatry, 118(4), 22–29. https://www.researchgate.net/publication/325375504
16. Ionescu, M., Frohman, L. A., & Teichman, S. L. (2006). Pulsatile secretion of development hormone persists throughout steady stimulation by CJC-1295, a long-acting development hormone-releasing hormone analog. Journal of Scientific Endocrinology & Metabolism, 91(12), 4792-4797. https://pubmed.ncbi.nlm.nih.gov/17018654/ 
17. Józwiak, M., Kaczmarek, Ok., & colleagues. (2025). Multifunctionality and attainable medical utility of the BPC 157 peptide: Literature and patent evaluation. Prescription drugs, 18(2), 185. https://doi.org/10.3390/ph18020185
18. Khavinson, V. Ok., Gomilko, A. P., & Morozov, V. G. (2003). Lengthy-term examine of the peptide bioremediator Epithalon in a geriatric inhabitants. Advances in Gerontology, 12, 115–121.
19. Lee, E., & Padgett, B. (2021). Intra-Articular Injection of BPC 157 for A number of Forms of Knee Ache. Various therapies in well being and medication, 27(4), 8–13. https://pubmed.ncbi.nlm.nih.gov/34324435/
20. Low, T. L., Hu, S. Ok., & Goldstein, A. L. (1981). Full amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase exercise in thymocyte populations. Proceedings of the Nationwide Academy of Sciences of the US of America, 78(2), 1162–1166. https://doi.org/10.1073/pnas.78.2.1162
21. Madsbad, S., Bradford, B., Pedersen, O., Wright, D., & Bowles, R. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a selective development hormone secretagogue, in people. Journal of Scientific Endocrinology & Metabolism, 84(10), 3636–3641. https://link.springer.com/article/10.1023/A:1018955126402
22. Maar, Ok., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., & Bock-Marquette, I. (2021). Using Developmentally Important Secreted Peptides Comparable to Thymosin Beta-4 to Remind the Grownup Organs of Their Embryonic State—New Instructions in Anti-Getting older Regenerative Therapies. Cells, 10(6), 1343. https://doi.org/10.3390/cells10061343 
23. McGuire, F. P., & colleagues. (2025). Regeneration or danger? A story evaluation of BPC-157 for musculoskeletal therapeutic. Present Critiques in Musculoskeletal Drugs. https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/ 
24. Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986). Preproglucagon gene expression in pancreas and gut diversifies on the degree of post-translational processing. The Journal of organic chemistry, 261(25), 11880–11889. https://pubmed.ncbi.nlm.nih.gov/3528148/
25. Pickart, L., & Thaler, M. M. (1973). Tripeptide in human serum which prolongs survival of regular liver cells and stimulates development in neoplastic liver. Nature New Biology, 243(124), 85–87. https://pubmed.ncbi.nlm.nih.gov/4349963/
26. Pickart, L., & Margolina, A. (2018). Regenerative and Protecting Actions of the GHK-Cu Peptide within the Mild of the New Gene Knowledge. Worldwide journal of molecular sciences, 19(7), 1987. https://doi.org/10.3390/ijms19071987
27. Polunin, G. S., Makarov, I. A., & Shmyreva, D. N. (2012). Scientific evaluation of the therapeutic effectivity of a brand new home nootropic medicine Semax in the remedy of optic nerve atrophy. Vestnik Oftalmologii, 128(1), 34–38.
28. Prakash, A., & Goa, Ok. L. (1999). Sermorelin: A evaluation of its use within the prognosis and remedy of youngsters with idiopathic development hormone deficiency. BioDrugs, 12(2), 139–157.https://europepmc.org/article/MED/18031173
29. Radionova, Ok. S., Kozlovskaya, M. M., & Seredenin, S. B. (2011). The regulatory peptide Selank blocks stress-induced modifications within the cytokine stability in sufferers with nervousness problems. Bulletin of Experimental Biology and Drugs, 151(6), 701–704.
30. Sikiric, P., et al.. (1994). The helpful impact of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative examine with H2 receptor antagonists, dopamine promoters and intestine peptides. Life sciences, 54(5), PL63–PL68. https://pubmed.ncbi.nlm.nih.gov/7904712/ 
31. Sikiric, P., et al. (2019). Steady gastric pentadecapeptide BPC 157, Robert’s abdomen cytoprotection/adaptive cytoprotection and abdomen organoprotection. Biomedicines, 7(1), 11. https://pubmed.ncbi.nlm.nih.gov/31158953/ 
32. Seiwerth, S., Rucman, R., Turkovic, B., et al. (2021). Steady gastric pentadecapeptide BPC 157 and wound therapeutic. Frontiers in Pharmacology, 12, 627533. https://doi.org/10.3389/fphar.2021.627533
33. Stanley, T. L., Feldpausch, M. N., Oh, J., Department, Ok. L., Lee, H., Torriani, M., & Grinspoon, S. Ok. (2019). Results of tesamorelin on non-alcoholic fatty liver illness in HIV: A randomized, double-blind, placebo-controlled trial. The Lancet HIV, 6(12), e821–e830. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30338-8/abstract 
34. Teichman, S. L., Neale, A., Lawrence, B., et al. (2006). Extended stimulation of development hormone and insulin-like development issue I secretion by CJC-1295, a long-acting analog of development hormone-releasing hormone, in wholesome adults. Journal of Scientific Endocrinology & Metabolism, 91(3), 799-805. https://doi.org/10.1210/jc.2005-1536
35. Wan, W., Zhang, L., Lin, Y., Zhang, Y., Wu, C., Liu, H., Liu, Ok., & Zhang, H. (2023). Mitochondria-derived peptide MOTS-c: Results and mechanisms associated to emphasize, metabolism and getting older. Journal of Translational Drugs, 21, 36. https://doi.org/10.1186/s12967-023-03885-2
36. Wessells, H., Levine, N., Hadley, M. E., Hruby, V. J., Dorr, R., & Juarez, M. (1998). Artificial melanotropic peptide initiates erections in males with psychogenic erectile dysfunction: Double-blind, placebo managed crossover examine. The Journal of Urology, 160(2), 389–393. https://www.sciencedirect.com/science/article/abs/pii/S0022534701629033
37. Zheng Y, Wei Z and Wang T (2023) MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Entrance. Endocrinol. 14:1120533. doi: 10.3389/fendo.2023.1120533
38. Zozulya, A. A., Neznamov, G. G., Suesha, Ok. A., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., … & Seredenin, S. B. (2008). Efficacy and mechanisms of motion of the brand new peptide anxiolytic Selank within the remedy of generalized nervousness dysfunction and neurasthenia. Journal of Neurology and Psychiatry, 108(4), 38–46. https://www.researchgate.net/publication/299052506